Skip to main content

Table 2 Summary of selected patient responses to the SOQ

From: The impact of frequent injections for hematopoietic growth factor support on patients receiving chemotherapy: an observational study

Effect of treatment on time commitment

Mean (SD) travel time to/from the clinic

60 (48) minutes per visit

Mean (SD) waiting time at the clinic

18 (24) minutes per visit

Effect of treatment on patient attitude

Attitude towards travel for treatment during first chemotherapy cycle

Moderately to extremely bothered, 45%

Attitude towards travel for treatment during second chemotherapy cycle

Moderately to extremely bothered, 59%

Disruption of daily activities caused by injection frequency

Reported disruption some to all of the time, 44%

Disruption of work schedule caused by injection frequency

Took time off from work for treatment some to all of the time, 18%

Effect of treatment on patient satisfaction and drug preference

Experience with Filgrastim therapy after most recent chemotherapy cycle

Moderately to very much satisfied, > 90%

Choice between daily injections versus newer, longer-acting drug

Preference for new drug, 89%